APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova
Becomes the 1st diagnostics company in India to launch BD MAX MDR TB test
The players and management of Mumbai City FC presented patients with exclusive gifts, symbolizing support and appreciation for their fight against cancer
The company has reported total income of Rs. 1.56 crores during the period ended June 30, 2022
The company has reported total income of Rs. 1097.78 crores during the period ended June 30, 2022.
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
The abstract is about the cohort A, stage I of the ongoing global phase ? trial that evaluating the safety and efficacy of Catumaxomab in advanced GC patients with peritoneal metastasis
The company has posted net profit of Rs.605.05 crores for the Financial Year ended March 31, 2022
The new building is expected to be commissioned by 2024. Post the expansion, Nanavati-Max Hospital will be amongst the largest private sector hospital in western India
Subscribe To Our Newsletter & Stay Updated
